Donald Trump tweeted that he supported a Republican health care bill to replace Obamacare that was unveiled in the Senate. » Read More
By: Kelly Song
Senate health care bill could have hidden future costs for investors, according to the former CEO of Molina. » Read More
By: Michael Sheetz
A recent shift in the European political landscape means there are 'simply better opportunities overseas,' an analyst says. » Read More
By: Dan Mangan
Republicans can afford to have no more than two members of their Senate caucus defect if they hope to pass a new health-care reform bill. » Read More
A Kentucky town that stands to lose much health coverage under the GOP's American Health Care Act is still voting Republican, Vox reports.
Trump's visit comes as GOP leaders in the Senate move toward potentially introducing health-care reform legislation soon.
Jim Cramer dissects one scary investment combination and how to play it, despite scary media headlines.
Trump's budget slashers are the real 'takers in the Medicaid debate, says Harvard Professor Kathleen Swartz.
President Donald Trump will huddle with congressional leaders on Tuesday, seeking to rev up a stalled legislative agenda as the summer break draws closer.
There's more than one way to cover the cost of care for a child with special needs. Here's how to plan for it.
Anthem pointed to continued "volatility" in the individual plan market.
If you are black or Hispanic, you're less likely to get effective health care than if you are white.
A group of researchers has outlined a roadmap to making personalized medicines available to patients in the near future.
CNBC's Meg Tirrell talks to Nick Leschly, Bluebird Bio CEO from ASCO, talks about the company's way of targeting blood cancer.
Mylan has been called out countless times and hasn't changed, even as revenue has skyrocketed, hitting $11 billion last year, N.Y. Times reports.
Incyte CEO Herve Hoppenot speaks with CNBC's Meg Tirrell from the ASCO conference on the future of cancer treatment.
Regulatory approval is in sight for Lynparza on promising late-stage clinical trial results, Financial Times reports.
CNBC's Meg Tirrell talks to Dr. Roger Perlmutter, president of Merck Research Laboratories, about Merck's recent FDA approval for Keytruda, live at the ASCO.
Bristol-Myers Squibb CEO Giovanni Caforio speaks to CNBC's Meg Tirrell at the American Society of Clinical Oncology conference, about drug pricing, the company's development and M&A in the space.
Juno Therapeutics President & CEO Hans Bishop speaks with CNBC's Meg Tirrell from the ASCO conference on Monday.
AdhereTech makes a smart pill bottle to help patients take their prescription medications correctly.
CNBC's Meg Tirrell reports on the latest breakthroughs in cancer research from the American Society of Clinical Oncology Conference.
Roche Pharmaceuticals CEO Daniel O'Day speaks with CNBC's Meg Tirrell on three new cancers studies that the company conducted.
Health savings accounts, which offer tax advantages, can be used to pay for medical expenses now and in retirement.
Get the best of CNBC in your inbox